Chloride Imbalance in Very Preterm Infants

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes medical records from the past five years to examine whether low or high chloride levels in extremely preterm infants are associated with death or chronic lung issues. It focuses on infants born before 32 weeks gestation or weighing less than 1500 grams who were in the NICU within 24 hours of birth. The goal is to identify risk factors and conditions linked to dyschloremia in this population. The study builds on existing knowledge that dyschloremia relates to mortality and organ injury in other groups, and seeks to determine relevance in preterm infants. Results could inform monitoring and management of chloride balance in the NICU.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Infants born \<32 weeks PMA or \<1500 grams
* Infants admitted to NICU within the first 24 hours

Exclusion Criteria:

* Infants with major congenital anomalies
* Infants with chromosomal anomalies
* Infants who have undergone enterostomy operation
* Infants admitted to NICU after the first 24 hours

Where it's running

• Kanuni Sultan Suleyman Education and Research Hospital
  Istanbul, Turkey, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Murat Köstü
• Email: murat.kostu@saglik.gov.tr
• Phone: +905323932616

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Testing an ICU time-series model to predict mortality at a major hospital

  We will see if a pre-trained time-series model can accurately forecast outcomes for ICU patients using real-world data.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07795450

• Can blood and physical tests before transplant predict non-relapse mortality

  This study tests whether pre-transplant blood markers and physical tests can predict non-relapse mortality in adults undergoing stem cell therapy.

  Recruiting Henry Ford Health System · Detroit, Michigan · NCT07769151

• Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency

  This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.

  Recruiting at 4 sites University Hospital, Bordeaux · Bron and 3 other locations · NCT07715617

• Enteral DHA and ARA Supplementation for Very Preterm Infants with BPD Risk

  This study tests whether giving a specific mix of DHA and ARA through feeding helps prevent bronchopulmonary dysplasia in extremely and very preterm babies.

  Recruiting Phase 4 Aristotle University Of Thessaloniki · Thessaloniki · NCT07652684

• Continuing CPAP protection for extremely preterm babies to reduce BPD or death

  This study tests whether keeping CPAP up to 34 weeks' PMA or for at least 2 more weeks, instead of weaning to a nasal cannula, lowers the chance of bronchopulmonary dysplasia or death by 36 weeks' PMA in babies born before 29 weeks gestation.

  Recruiting at 15 sites NICHD Neonatal Research Network · Birmingham, Alabama and 14 other locations · NCT07417111

• Lung ultrasound and lactate at discharge to predict 30-day outcomes after acute heart failure

  We’re testing whether a combination of lung ultrasound and blood lactate at discharge can help predict who will be readmitted or die within 30 days after leaving the hospital for acute heart failure.

  Recruiting University of Monastir · Monastir, Monastir Governorate · NCT07345156

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.